Evidence map›Paper›PMID 40537726›Full record

Observational studyClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2025

Development of a practice-based score to predict extended duration of proton beam therapy session in pediatric patients.

José M Fernández-de Miguel, Miguel Ángel García-Aroca, Ignacio Manrique Yera, Felipe A Calvo, María Aymerich de Francesci, Jose Manuel Álvarez Avello, Elena Panizo Morgado, Jorge M Núñez-Córdoba

Abstract readObservational Study
In one paragraph

Observational study in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

José M Fernández-de MiguelDepartment of Anaesthesia and Critical Care, Clínica Universidad de Navarra, Madrid, Spain.
Miguel Ángel García-ArocaDepartment of Anesthesia and Intensive Care, HCD "Gómez-Ulla", Madrid, Spain.
Ignacio Manrique YeraOperations Department and Protontherapy Unit, Clínica Universidad de Navarra, Madrid, Spain.
Felipe A CalvoDepartment of Radiation Oncology, Cancer Center, Clinica Universidad de Navarra, Madrid, Spain.
María Aymerich de FrancesciDepartment of Anaesthesia and Critical Care, Clínica Universidad de Navarra, Madrid, Spain.
Jose Manuel Álvarez AvelloDepartment of Anaesthesia and Critical Care, Clínica Universidad de Navarra, Madrid, Spain.
Elena Panizo MorgadoDepartment of Pediatric Oncology, Clínica Universidad de Navarra, Madrid, Spain.
Jorge M Núñez-CórdobaResearch Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Pio XII, 36, 31008, Pamplona, Spain. jnunezco@unav.es.ORCID http://orcid.org/0000-0003-0550-1069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeDue to the labor intensity demanded by proton beam therapy (PBT) in pediatric patients, information on operational procedures related to efficiency is crucial to optimize quality and safety. We aimed to identify patient factors that affect the duration of the pediatric PBT session and to develop an easy-to-use predictive score of extended duration. METHODS/PATIENTS: This is an observational retrospective cohort study in an academic medical centre, between May 2020 and February 2024. Seventy seven ASA III pediatric patients treated with PBT were recruited.

resultsThe mean age was 4.8 years [standard deviation (SD): 2.1] and 52% were women. The mean duration of the PBT session was 50 min (SD: 17). Extended duration of the PBT session (> 45 min) occurred in 39 patients (51%). Five predictors of extended duration were selected for the final prediction model. In the multivariable model, an age > 45 months showed a near eightfold increased odds of extended duration [Odds ratio (OR): 7.76, 95% confidence interval (95% CI) 1.63-36.99, P = 0.010]. The OR (95% CI) for long-term venous access, no recurrent tumors, hydrocephalus, and craniospinal location were 5.91 (1.47 to 23.79), 3.81 (0.67 to 21.69), 3.79 (0.90 to 15.97), and 2.59 (0.69 to 9.76), respectively. This five-variable model was used to build a nomogram-based score with an area under the receiver operating characteristic curve of 0.84 (95% CI 0.76-0.93).

conclusionsA simple nomogram based on readily available pretreatment data has potential for planning pediatric PBT standard clinical expert practice.

Indexed as

NeoplasmsProton TherapyChildChild, PreschoolFemaleHumansInfantMaleRetrospective StudiesTime FactorsPediatric cancerProton beam therapyTreatment planning

Identifiers

PMID40537726
PMCPMC12630184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.